---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-115498"
form_type: "8-K"
ticker: "ACU"
cik: "0000002098"
company_name: "ACME UNITED CORP"
filed_at: "2024-10-18T23:59:59+00:00"
generated_at: "2026-05-30T12:52:53.042833+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Acme United Q3 net income rises 3% to $2.23M despite 4% sales decline

## Summary
- Net income $2.23M ($0.54/diluted) vs $2.15M ($0.58) in Q3 2023; net income up 3%, EPS down 7%.
- Net sales $48.2M, down 4% YoY; excluding Camillus/Cuda (sold Nov 2023), sales up 4%.
- U.S. segment sales down 6% (ex-div up 3%); Europe up 10% in USD; Canada down 1% (up 2% local).
- Bank debt less cash $26.7M at Sep 30, 2024 vs $38.2M a year ago; generated $6.2M free cash flow.
- Introduced next-gen industrial first aid kits with patent-pending real-time expiration monitoring.

## SEC filing metadata
- accession: 0000950170-24-115498
- form_type: 8-K
- ticker: ACU
- cik: 0000002098
- company_name: ACME UNITED CORP
- filed_at: 2024-10-18T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2098/000095017024115498/0000950170-24-115498-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2098/000095017024115498/acu-20241018.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-115498
- JSON: https://secwatch.observer/filing/0000950170-24-115498.json
- Plain text: https://secwatch.observer/filing/0000950170-24-115498.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.